Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Search Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

In the Spotlight

Join us in New York

This exciting one-day seminar provides attendees with a unique opportunity to hear in-depth analysis of hot topics and trends concerning global biosimilars while engaging directly with Decision Resources Group analysts.

View the Agenda  |  Meet our expert speakers

Register

 


Recent Reports [ view all ]

  • What Market Access Challenges and Opportunities Lie Ahead for Emerging SLE Biologics?

    Benlysta (GlaxoSmithKline) is not only the first drug approved for systemic lupus erythematosus (SLE) in more than 50... Read More

  • Sweden: Market Access Tracker - 2014

    Last Updated 30 September 2014
    Although Sweden’s pharmaceutical market is relatively small compared... Read More

  • Crohn's Disease - 2014

    Last Updated 29 September 2014

    Treatment options for Crohn’s disease (CD) include conventional, largely... Read More

Decision Resources Group brands include: